RESUMEN
Thermoluminescent (TL) response of trivalent praseodymium ion doped lanthanum aluminate (LaAlO3:Pr3+) obtained by Pechini method and Spray Dryer was studied. TL response of LaAlO3:Pr3+ powders submitted at 1600°C exhibited one peak centered at 157°C. Sensitivity of LaAlO3:Pr3+ was improved in around 90 times compared with undoped LaAlO3. TL response as a function of wavelength showed a maximum in 230nm. Dosimetric characteristics of LaAlO3:Pr3+ under UVR radiation effects were analyzed. Evaluation of activation energy was obtained by Glow Fit v.1.3 software. Experimental results about thermoluminescent characteristics of LaAlO3:Pr3+ suggest as good candidate to be employed as a complementary thermoluminescent device with other TL phosphors as aluminum oxide.
RESUMEN
This paper presents results of equivalent dose organ determining to both primary beam and scattered radiation in a computed tomography (CT) procedures. All measurements were carried out to abdomen and critical organ (gonads) area. Selected dosimeters showed a standard deviation of 4.1% below to the reference values established by international guide lines. The equivalent dose in gonads was 14.27 mGy.
Asunto(s)
Pelvis/efectos de la radiación , Dosimetría Termoluminiscente , Tomografía Computarizada por Rayos X/métodos , Abdomen/efectos de la radiación , Rayos gamma , Humanos , Fantasmas de Imagen , Protección Radiológica/métodos , Dispersión de RadiaciónRESUMEN
Se ha medido la dosis en la superficie de entrada de ojos, tiroides y gónadas en pacientes sometidos a estudio de radiografía de tele de tórax mediante dosimetría termoluminiscente. Se usaron 5 dosímetros en cada una de las exploraciones; encontrándose los siguientes rangos de dosis: 20 mGy a 350 mGy. En el caso de los pacientes pediátricos se propone incluir la información de las dosis recibidas en su cartilla de vacunación con el fin de hacer un seguimiento de los posibles efectos nocivos en su salud.
Doses have been measured at the entrance surface of eyes, thyroid and gonads in patients undergoing chest x-ray studies, using thermo-luminiscent dosimetry. Five dosimeters were used in each investigation, and doses ranged from 20 mGy to 350 mGy. In the case of pediatric patients, it is proposed that dose information from diagnostic examinations is included in the vaccination chart in order to correlate with findings at follow-up.
Asunto(s)
Humanos , Femenino , Recién Nacido , Persona de Mediana Edad , Dosimetría Termoluminiscente , Glándula Tiroides , Gónadas , Ojo , Radiometría/métodos , Dosis de Radiación , Glándula Tiroides/efectos de la radiación , Gónadas/efectos de la radiación , Ojo/efectos de la radiación , Protección Radiológica/métodos , Radiografía TorácicaRESUMEN
Thermoluminescent response of LiF:Mg,Cu,P+PTFE under clinical photon irradiation was obtained. Thermoluminescent dosimeters (TLDs) were irradiated for determining entrance surface dose (ESD) in a solid water phantom when using standard clinical adult treatment protocols. A Monte Carlo simulation of photon interaction with matter was performed and absorbed dose determined. ESD calculated by MCNPX code was greater than those determined by direct measurements in phantom. The results obtained open the possibility for using this material as a TLDs in medical accelerators.
Asunto(s)
Modelos Estadísticos , Método de Montecarlo , Dosimetría Termoluminiscente/instrumentación , Simulación por Computador , Fotones/uso terapéutico , Protones , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
Hafnium oxide (HfO(2)) films were deposited by the ultrasonic spray pyrolysis process. The films were synthesized from hafnium chloride as raw material in deionized water as solvent and were deposited on corning glass substrates at temperatures from 300 to 600 degrees C. For substrate temperatures lower than 400 degrees C the deposited films were amorphous, while for substrate temperatures higher than 450 degrees C, the monoclinic phase of HfO(2) appeared. Scanning electron microscopy showed that the film's surface resulted rough with semi-spherical promontories. The films showed a chemical composition close to HfO(2), with an Hf/O ratio of about 0.5. UV radiation was used in order to achieve the thermoluminescent characterization of the films; the 240 nm wavelength induced the best response. In addition, preliminary photoluminescence spectra, as a function of the deposition temperatures, are shown.
Asunto(s)
Hafnio/química , Mediciones Luminiscentes/métodos , Membranas Artificiales , Óxidos/química , Termografía/métodos , Hafnio/efectos de la radiación , Óxidos/efectos de la radiación , Temperatura , Rayos UltravioletaRESUMEN
The uptake of the rhenium-188 (188Re(V)-DMSA) complex of dimercaptosuccinic acid by cervical carcinoma cells in nude mice was evaluated. The pharmacokinetics and dosimetry calculations in normal rats were also evaluated. The images obtained in mice did not show significant accumulation in metabolic organs and the biodistribution studies showed that 3.52 +/- 0.76% of the injected activity per gram (n = 4) was taken up by the tumor. This percentage produces a cumulated activity of 35.63 +/- 8.40 MBq h and an equivalent dose per injected activity of 260 +/- 8.91 mSv/MBq. Pharmacokinetics and dosimetry of the 1887e(V)-DMSA complex indicate that this radiopharmaceutical could be evaluated in patients with soft tissue tumors, since the risk of radiation damage to the kidney or red bone marrow could not be an obstacle for its application in therapeutic nuclear medicine.